Faculty of Pharmaceutical Sciences is where great minds make a difference. The Faculty enjoys an international reputation for outstanding pharmaceutical sciences research. Across a broad base of collaborative, paradigm-shaping pilot projects, our world-leading researchers generate relevant results that address the pressing health needs of society. In short, our work improves lives.

If you are passionate about health sciences research that makes a difference in people's lives, you're in good hands. We offer award-wining graduate programs led by world-class researchers. You'll have access to top-tier facilities and be working alongside the best and brightest in the field, conducting research that addresses real life problems. Our paradigm-changing approach is collaborative, innovative, and results-driven.

We're tackling diseases like asthma / chronic obstructive pulmonary disease, diabetes, cancer, heart disease, and arthritis. We're developing better ways to deliver drugs and prevent adverse drug reactions. And we're conducting clinical and economic research in pharmaceutical outcomes. 

Our reputation as a top research centre attracts some of the brightest and most productive minds in the field. Our faculty includes Canada Research Chairs, Michael Smith Foundation for Health Research Scholars and Senior Scholars, and Distinguished University Scholars.


We are innovators in pharmacy education, research and practice, with the goal of supporting the optimization of drug therapy in the pursuit of improved patient outcomes.


  • We support our people, creating a community that enables excellence through collective action.
  • We seek novel ideas, putting into practice those with the greatest scope for sustained impact.
  • We search for relevant connections, fostering meaningful collaborations that provide mutual benefit.

Research Centres

adMare BioInnovations is located in our building. It is an independent, non-profit organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. The Faculty partners with adMare BioInnovations to provide unique research and mentoring opportunities for MSc and PhD students. 

We are also home to several sophisticated research centres that specialize in the areas of human genome and exome sequencing, and health outcomes research.

Research Facilities

Opened in 2012, the Pharmaceutical Sciences Building at UBC is a state-of-the-art learning and research facility. The building houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities are fitted with advanced technology to facilitate new modes of learning.

Measuring 246,000 square feet, it's an eye-catching addition to our campus, and has drawn attention and admiration from around the world—including 15 awards of excellence. 

Research Highlights

As a leading research faculty, we conduct ground-breaking research in the pharmaceutical sciences – all with the goal of addressing the pressing health needs of society and improving lives. Our research activities centre around four areas of focus.

Epidemiology & Health Outcomes

This theme covers our activities in epidemiological analysis, health outcomes and health economics research seeking solutions for the predictive enhancement of intervention strategies for practical and preventive healthcare. The impact of this work is used to shape policy to optimize the allocation of health care resources as well as defining the efficacy of healthcare interventions and strategy.

Molecular & Systems Pharmacology

This highly interdisciplinary theme embodies research directed at the interactions of therapeutic agents with human cells, and covers fundamental questions of the mechanisms of the drug action through to the behaviour of drugs in human systems. These studies are used to inform and optimize the development and delivery of drug intervention regimes for clinical practice and the pharmaceutical industry.

Nanomedicine & Chemical Biology

This theme applies our expertise in the chemical biology of the fabrication and handling of nanoscopic materials to drug discovery and delivery. Sensing and screening technologies are also an important focus.

Pharmacy Education

Our research in this theme addresses the issue of scholarship in pharmacy and the pharmaceutical sciences with a view to augment our educational research capacity and enhance the methodologies of teaching practice, student learning and curriculum decision-making.

Explore Research Themes

Recent Publications

This is an incomplete sample of recent publications in chronological order by UBC faculty members with a primary appointment in the Faculty of Pharmaceutical Sciences.


Recent Thesis Submissions

Doctoral Citations

A doctoral citation summarizes the nature of the independent research, provides a high-level overview of the study, states the significance of the work and says who will benefit from the findings in clear, non-specialized language, so that members of a lay audience will understand it.
Year Citation Program
2011 Dr. Patankar is helping to fight recurrent ovarian cancer. He demonstrated the benefit of incorporating the anti-cancer drug topotecan into lipid nanoparticles in order to improve its activity either as a stand-alone therapy or in combination with an existing formulation of doxorubicin which is already approved for use in patients. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2010 Dr. Guo measured quality of life and treatment preferences among tuberculosis patients, which showed the impact of tuberculosis and its treatment from the patient?s perspective. This research could help inform the patient-centered health care management by understanding patients? personal preferences and values toward disease and treatment. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2010 Dr. Bains demonstrated that genetic variations in human reductase enzymes significantly decrease the metabolism of the highly used anti-cancer drugs, doxorubicin and daunorubicin. His findings may lead to the establishment of biomarkers, which would prevent life-threatening side-effects in cancer patients undergoing treatment with these drugs. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2010 Dr. Yang examined the regulatory effects of parathyroid hormone treatments on mesenchymal stem cells and developed localized, biodegradable polymer scaffold-based delivery systems for parathyroid hormone and mesenchymal stem-cells for bone regeneration applications in orthopedic medicine. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2010 Dr. Vasudevan investigated the effects of testosterone on the development of insulin resistance and hypertension. His identification of two key testosterone-dependent biochemical pathways furthers our understanding of the role of sex hormones in regulating the actions of insulin and the resultant changes in blood pressure. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2010 Dr. Takahashi examined how known genetic changes affect the function of a human enzyme that is responsible for deactivating androgen steroids. The findings of these studies are being used as a basis to investigate the links between genetics, the concentrations of androgen steroids, and a man's risk for developing prostate cancer. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2010 Dr. Kim determined control of cardiomyocyte lipoprotein lipase secretion following diabetes. These studies will assist us in understanding the mechanisms by which excessive lethal fatty acids are delivered to hearts in diabetic patients. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2010 Dr. Kiang used a variety of experimental models to study liver toxicity associated with valproic acid, a popular anti-epileptic drug. His results help us understand the roles of metabolism, oxidative stress, and mitochondrial dysfunction in valproic acid-induced liver toxicity. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2009 Dr. Nagareddy showed how activation of protein kinase C and matrix metalloproteinases affects the regulation of blood pressure in diabetes. His research provides novel insights into our understanding of the etiology of diabetic vascular disease and offers potential therapeutic strategies in the management of hypertension associated with diabetes. Doctor of Philosophy in Pharmaceutical Sciences (PhD)
2009 Dr. Kewalramani identified three new roles of cardiac AMPK, a protein at center stage in studies of diabetes. His research unfolds complex functions of this protein in a diabetic heart and contributes to our understanding of this emerging drug target for diabetes. Doctor of Philosophy in Pharmaceutical Sciences (PhD)